appendix 6: Chronic lymphocytic leukaemia: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Haematological-Malignancies)
- 23 September 2016
- journal article
- research article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 27 (suppl_5), v143-v144
- https://doi.org/10.1093/annonc/mdw359
Abstract
clinical practice guidelines eUpdate. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [Ann Oncol 2015; 26 (Suppl 5): v78-v84.]This publication has 4 references indexed in Scilit:
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2015
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialThe Lancet, 2010
- Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysisLeukemia & Lymphoma, 2009
- Intravenous Immunoglobulin for the Prevention of Infection in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1988